08:08 AM EST, 11/06/2024 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) reported a Q3 loss Wednesday of $0.95 per diluted share, narrower than the $1.03 loss a year earlier.

Analysts polled by Capital IQ expected a loss of $1.16.

Revenue for the quarter ended Sept. 30 was $134 million, compared with $144 million a year earlier.

Analysts surveyed by Capital IQ expected $134 million.